We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COHR
251
DELISTED
Coherent Inc
COHR
$11.4M 0.08%
45,763
ORCL icon
252
Oracle
ORCL
$339B
$11.4M 0.08%
130,627
-42,442
-25% -$3.75M
TWLO icon
253
Twilio
TWLO
$28.6B
$11.4M 0.08%
35,588
+20,965
+143% +$7.63M
CFG icon
254
Citizens Financial Group
CFG
$30.1B
$11.1M 0.08%
236,742
-36,416
-13% -$1.6M
CAT icon
255
Caterpillar
CAT
$361B
$11.1M 0.08%
57,888
-1,439
-2% -$300K
ZLAB icon
256
Zai Lab
ZLAB
$2.07B
$11M 0.07%
104,315
+38,667
+59% +$5.55M
MBT
257
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$11M 0.07%
1,136,000
+572,000
+101% +$5.15M
EQR icon
258
Equity Residential
EQR
$25.8B
$10.9M 0.07%
135,237
+102,825
+317% +$8.49M
XENE icon
259
Xenon Pharmaceuticals
XENE
$6.1B
$10.9M 0.07%
715,722
ZBH icon
260
Zimmer Biomet
ZBH
$18.8B
$10.8M 0.07%
72,718
-92,464
-56% -$13.6M
MCO icon
261
Moody's
MCO
$83.7B
$10.8M 0.07%
30,330
-337
-1% -$127K
PAGS icon
262
PagSeguro Digital
PAGS
$2.67B
$10.7M 0.07%
206,350
+14,600
+8% +$819K
WAT icon
263
Waters Corp
WAT
$37.3B
$10.7M 0.07%
29,825
+4,713
+19% +$1.85M
BABA icon
264
Alibaba
BABA
$276B
$10.4M 0.07%
70,393
-405,700
-85% -$73.8M
ETSY icon
265
Etsy
ETSY
$8.12B
$10.4M 0.07%
50,114
+27,978
+126% +$5.67M
DE icon
266
Deere & Co
DE
$165B
$10.4M 0.07%
31,027
+766
+3% +$276K
ZTS icon
267
Zoetis
ZTS
$32.7B
$10.3M 0.07%
53,180
-636
-1% -$128K
KSU
268
DELISTED
Kansas City Southern
KSU
$10.2M 0.07%
37,848
-7,137
-16% -$1.99M
PTCT icon
269
PTC Therapeutics
PTCT
$6.18B
$10.2M 0.07%
273,374
MTN icon
270
Vail Resorts
MTN
$5.7B
$10M 0.07%
29,926
-19,431
-39% -$5.99M
DGX icon
271
Quest Diagnostics
DGX
$26B
$9.96M 0.07%
68,549
-1,946
-3% -$285K
ALLK
272
DELISTED
Allakos
ALLK
$9.87M 0.07%
93,204
+27,150
+41% +$2.43M
RDNT icon
273
RadNet
RDNT
$4.98B
$9.85M 0.07%
336,211
+27,000
+9% +$866K
ZS icon
274
Zscaler
ZS
$24.9B
$9.77M 0.07%
37,272
-25,642
-41% -$6.44M
CLDX icon
275
Celldex Therapeutics
CLDX
$2.94B
$9.73M 0.07%
180,222
-219,463
-55% -$10.3M

Similar funds

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.